{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:01:21Z","timestamp":1790179281716,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.carrev.2020.09.027","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T12:25:47Z","timestamp":1600863947000},"page":"12-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Ultrathin Biodegradable-Polymer Orsiro Drug-Eluting Stent Performance in Real Practice Challenging Settings"],"prefix":"10.1016","volume":"30","author":[{"given":"Gianluca","family":"Rigatelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Gianese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Adami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"dell'Avvocata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Barison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Picariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"Roncon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2020.09.027_bb0005","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4244\/EIJV8I9A155","article-title":"Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study","volume":"8","author":"Hamon","year":"2013","journal-title":"EuroIntervention."},{"key":"10.1016\/j.carrev.2020.09.027_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001441","article-title":"Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial","volume":"8","author":"Windecker","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.09.027_bb0015","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4244\/EIJY15M03_08","article-title":"Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry","volume":"11","author":"Waltenberger","year":"2016","journal-title":"EuroIntervention."},{"key":"10.1016\/j.carrev.2020.09.027_bb0020","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4244\/EIJ-D-16-00179","article-title":"Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and resolute integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial","volume":"12","author":"Kang","year":"2017","journal-title":"EuroIntervention."},{"key":"10.1016\/j.carrev.2020.09.027_bb0025","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(19)31877-X","article-title":"Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial","volume":"394","author":"Iglesias","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.carrev.2020.09.027_bb0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcin.2016.10.017","article-title":"Randomized multicenter trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions: the PRISON IV trial","volume":"10","author":"Teeuwen","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.09.027_bb0035","article-title":"Three contemporary thin-strut drug-eluting stents implanted in severely calcified coronary lesions of participants in a randomized all-comers trial","author":"Buiten","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.09.027_bb0040","first-page":"219","article-title":"The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease","volume":"1","author":"Sianos","year":"2005","journal-title":"Eurointervention"},{"key":"10.1016\/j.carrev.2020.09.027_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1157\/13084649","article-title":"A new classification of coronary bifurcation lesions","volume":"59","author":"Medina","year":"2006","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.carrev.2020.09.027_bb0050","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2020.09.027_bb0055","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/01.CIR.100.18.1872","article-title":"Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome","volume":"100","author":"Mehran","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.09.027_bb0060","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1093\/eurheartj\/suy019","article-title":"Faculty for approval of the Consensus Document. Consensus Document ANMCO\/ANCE\/ARCA\/GICR-IACPR\/GISE\/SICOA: long-term antiplatelet therapy in patients with coronary artery disease","volume":"20","author":"Gulizia","year":"2018","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.carrev.2020.09.027_bb0065","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(18)31715-X","article-title":"Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial","volume":"392","author":"Pilgrim","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.carrev.2020.09.027_bb0070","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jcin.2020.02.019","article-title":"Ultrathin bioresorbable-polymer sirolimus-eluting stents versus thin durable-polymer everolimus-eluting stents for coronary revascularization: 3-year outcomes from the randomized BIOFLOW V Trial","volume":"13","author":"Kandzari","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.09.027_bb0075","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.clinthera.2020.02.014","article-title":"Comparison of the ultrathin strut, biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent in a Chinese population: the randomized BIOFLOW VI Trial","volume":"42","author":"Li","year":"2020","journal-title":"Clin Ther"},{"key":"10.1016\/j.carrev.2020.09.027_bb0080","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0140-6736(18)32001-4","volume":"392","author":"von Birgelen","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2020.09.027_bb0085","article-title":"Three-year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus-eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus-eluting stent: a randomized controlled trial","author":"Kim","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.09.027_bb0090","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jcin.2020.01.230","article-title":"Thin composite-wire-strut zotarolimus-eluting stents versus ultrathin-strut sirolimus-eluting stents in BIONYX at 2 years","volume":"13","author":"Buiten","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2020.09.027_bb0095","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1161\/CIRCULATIONAHA.119.040241","article-title":"Randomized comparison of the polymer-free biolimus-coated biofreedom stent with the ultrathin strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: the SORT OUT IX Trial","volume":"141","author":"Jensen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2020.09.027_bb0100","doi-asserted-by":"crossref","DOI":"10.1097\/MCA.0000000000000875","article-title":"Clinical outcomes three-year after revascularization with biodegradable polymer stents: ultrathin-strut sirolimus-eluting stent versus biolimus-eluting stent: from the Scandinavian organization for randomized trials with clinical outcome VII trial","author":"Ellert","year":"2020","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.carrev.2020.09.027_bb0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2018.02.014","article-title":"One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry)","volume":"260","author":"Godino","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2020.09.027_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.carrev.2020.04.021","article-title":"Safety and performance of the Orsiro sirolimus eluting stent in the treatment of all-comers patient population in daily clinical practice","author":"Boukhris","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2020.09.027_bb0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.carrev.2017.01.002","article-title":"Evaluation of coronary flow conditions in complex coronary artery bifurcations stenting using computational fluid dynamics: impact of final proximal optimization technique on different double-stent techniques","volume":"18","author":"Rigatelli","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2020.09.027_bb0120","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.amjcard.2020.03.005","article-title":"Risk of dislodgement of ultrathin drug eluting stents versus thick drug eluting stents","volume":"125","author":"Rigatelli","year":"2020","journal-title":"Am J Cardiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920305765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920305765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:21:11Z","timestamp":1761560471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838920305765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":24,"alternative-id":["S1553838920305765"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2020.09.027","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultrathin Biodegradable-Polymer Orsiro Drug-Eluting Stent Performance in Real Practice Challenging Settings","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2020.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}